| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | — | +0.0% |
| Cost of Revenue | $1.1M | — | +0.0% |
| Gross Profit | $166K | — | +0.0% |
| R&D Expense | $1.4M | — | +0.0% |
| SG&A Expense | $680K | — | -69.2% |
| Operating Income | -$680K | — | +86.6% |
| Interest Expense | $102K | — | -87.0% |
| Pre-tax Income | -$770K | — | +96.5% |
| Income Tax | $6K | — | +0.0% |
| Net Income | -$770K | — | +96.6% |
| EPS (Basic) | -$0.02 | — | +99.5% |
| EPS (Diluted) | -$0.02 | — | +99.5% |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $1.6M | +1.8% | +41.4% |
| Current Assets | $2.0M | -6.2% | -78.6% |
| Total Assets | $2.6M | -6.0% | -73.9% |
| Current Liabilities | $24.5M | +3.4% | +5.7% |
| Long-term Debt | $2.3M | -9.3% | +5.6% |
| Total Liabilities | $26.8M |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$59K | — | +97.3% |
| Capital Expenditures | $11K | — | +0.0% |
| Investing Cash Flow | -$11K | — | +0.0% |
| Financing Cash Flow | $6.1M | — | +0.0% |
| Free Cash Flow | -$70K | — | +96.8% |
| -13.4% |
| Stockholders' Equity | -$24.2M | -3.2% | -14.9% |